1 
A model for the physical optimization of external beam radiotherapyHolmes, Timothy William. January 1900 (has links)
Thesis (Ph.D.)University of WisconsinMadison, 1993. / Typescript. eContent providerneutral record in process. Description based on print version record. Includes bibliographical references (leaves 199207).

2 
Dose calculations relating to the use of negative pimesons for radiotherapyHenry, Marguerite Irene January 1973 (has links)
Physical (or absorbed) dose distributions and biologically effective
distributions are calculated in this thesis for
(a) monoenergetic beams
(b) "shaped" continuous energy spectra
of negative pimesons. The results of these calculations confirm qualitatively
the claims made for the advantages of negative pimesons for radiotherapy
and give some quantitative measures of these advantages.
The first and most detailed calculations include only dose contributions from primary pions and from the charged particles released in the nuclear disintegrations which occur at the end of the negative pion tracks. The physical dose calculations are based on published data on the number and energy of the charged particles from these disintegrations and on published rangeenergystopping power data for the primary pions and for the charged disintegration products. Two physical dose calculations are made, assuming (a) 29.0 MeV and (b) 35.6 MeV total kinetic energy per pion capture of the charged particles from the "stars". These calculations show that, for a monoenergetic beam having a 20 cm range, the dose at the Bragg peak is 10 to 12 times the entrance dose.
Biologically effective dose distributions are calculated, both for aerobic and for anoxic conditions, using available (but uncertain) data for the dependence of (a) "relative biological effectiveness" (RBE) and (b) "oxygen
enhancement ratio" (OER) on the stopping power of the medium. All calculations are repeated for two different assumptions with respect to dependence of "RBE" on stopping power. On the assumptions made, for a monoenergetic beam in the Bragg peak the effective RBE and the effective OER
are approximately 1.9 and 1.65, respectively, for the lower RBE values used and about 2.5 and 1.55, respectively, for the higher RBE values.
The calculations for continuous energy spectra of negative pions demonstrate the possibility of selecting a "shaped" spectrum which gives an essentially constant dose through a specified depth with a surface dose which is only 25 to 30% of this constant dose. For a spectrum chosen to give constant biologically effective dose from 12 to 20 cm depth, assuming the lower RBE values (referred to above), the effective RBE increases from about 1.35 at 12 cm to I.65 at 20 cm and the effective OER decreases from about 2.00 to 1.75 over the same depth interval. Assuming the higher RBE values, the corresponding range of effective RBE values is from 1.6 to 2.1 and the range of effective OER values I.85 to 1.65.
An attempt is made to estimate corrections for the effects which were neglected in the detailed calculations, namely, (a) muon and electron contamination of the incident pion beam, (b) loss of pions from the beam by interactions with nuclei of the medium before coming to rest and (c) dose contributions from neutrons released in the "stars" at the end of the pion tracks. When these corrections are made, it is shown for a monoenergetic beam of 20 cm range that the ratio of the maximum dose in the Bragg peak to the surface dose is about 6.5 in good agreement with published experimental results. Also, it is shown that, when all corrections are taken into account, for a "shaped" spectrum which delivers a constant physical dose from 12 to 20 cm depth, about 30% of the total energy absorbed in the patient is absorbed within the constant dose region.
Calculated values of RBE and OER are compared with published experimental values but the validity of the comparison is very questionable. / Science, Faculty of / Physics and Astronomy, Department of / Graduate

3 
Microdosimetry for a fast neutron therapy beamBinns, Peter Justin 24 August 2017 (has links)
No description available.

4 
Delivery verification and dose reconstruction in tomotherapy /Kapatoes, Jeffrey M. January 1900 (has links)
Thesis (Ph. D.)University of WisconsinMadison, 2000. / Includes bibliographical references (leaves 205212). Also available on the Internet.

5 
Delivery verification and dose reconstruction in tomotherapyKapatoes, Jeffrey M. January 1900 (has links)
Thesis (Ph. D.)University of WisconsinMadison, 2000. / eContent providerneutral record in process. Description based on print version record. Includes bibliographical references (leaves 205212).

6 
Biological optimization of angle of incidence and intensity modulation in breast and cervix cancer radiation therapy /Costa Ferreira, Brigida da, January 2004 (has links)
Diss. (sammanfattning) Stockholm : Univ., 2004. / Härtill 4 uppsatser.

7 
AgTPPS4 enhanced brachytherapy as a treatment for inoperable brain tumors /Young, Lori Ann Y.L. January 1998 (has links)
Thesis (Ph. D.)University of Washington, 1998. / Vita. Includes bibliographical references (leaves [110]117).

8 
Tomosynthesisbased intraoperative dosimetry for lowdose rate prostrate brachytherapyBrunetBenkhoucha, Malik, January 1900 (has links)
Written for the Medical Physics Unit. Title from title page of PDF (viewed 2009/06/19). Includes bibliographical references.

9 
Development and implementation of qualityassurance standards for external beam intensity modulated radiation therapyHack, Joshua. January 2009 (has links)
Thesis (M.S.)University of Toledo, 2009. / "In partial fulfillment of The Degree of Master of Science in Biomedical Sciences." Title from title page of PDF document. Bibliography: p. 94102.

10 
Development of a Monte Carlo Simulation Model for Varian ProBeam Compact SingleRoom Proton Therapy System using GEANT4Unknown Date (has links)
Proton therapy with pencil beam scanning technique is a novel technique to treat cancer patients due to its unique biophysical properties. However, a small error in dose calculation may lead towards undesired greater uncertainties in planed doses. This project aims to create a simulation model of Varian ProBeam Compact using the GEANT4 Monte Carlo simulation tool kit.
Experimental data from the first clinical ProBeam Compact system at South Florida Proton Therapy Institute was used to validate the simulation model. A comparison was made between the experimental and simulated Integrated DepthDose curves using a 2%/2mm gamma index test with 100% of points passing. The beam spot standard deviation sizes (s!) were compared using percent deviation. All simulated s! matched the experimental s! within 2.5%, except 70 and 80 MeV. The model can be used to develop a more comprehensive model as an independent dose verification tool and further investigate dose distribution. / Includes bibliography. / Thesis (M.S.)Florida Atlantic University, 2020. / FAU Electronic Theses and Dissertations Collection

Page generated in 0.1031 seconds